Curative
Curative Raises $150 million in Series B
Curative Raises $150 million in Series B
Curative has successfully raised $150 million in a Series B at a $1.275 billion valuation led by Upside Vision Fund.
Company Overview
Curative is a HealthTech company headquartered in Austin TX, founded in 2022 with 165000+ members employees.
Curative is a health insurance company providing AI-driven health benefits with a unique model centered on zero out-of-pocket costs including no co-pays deductibles or coinsurance for members who complete an annual preventative health visit. The company has achieved a 20% lift in primary care engagement and 30% reduction in hospitalizations.
Fundraising Details
- Amount Raised: $150 million
- Round Type: Series B
- Valuation: $1.275 billion valuation
- Date: 2025-12-02
- Investors: Upside Vision Fund and JAM Fund and Galaxy Digital and Duquesne Family Office and DCVC and Martin Varsavsky
About Curative
Curative is a health insurance company providing AI-driven health benefits with a unique model centered on zero out-of-pocket costs including no co-pays deductibles or coinsurance for members who complete an annual preventative health visit. The company has achieved a 20% lift in primary care engagement and 30% reduction in hospitalizations. The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Austin TX
- Founded: 2022
- Team Size: 165000+ members
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Curative's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Curative's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching $1.275 billion valuation marks an important milestone for Curative, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Curative is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-12-02. For more information about Curative, visit their headquarters at Austin TX.
Company Info
Investors (6)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free